Nanovesicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade

作者：Huimin Kong, Siqing Wang, Chenya Zhuo, Qingguo Zhong, Yanteng Xu, Yeh‐Hsing Lao, Shixian Lv, Xi Xie, Qing Yuan, Kai Li, Tao Yu, Mingqiang Li · 发表于：Journal of Controlled Release · 年份：2025 · DOI：10.1016/j.jconrel.2025.114480 · 被引用次数：2 · 研究领域：Phagocytosis and Immune Regulation、Nanoplatforms for cancer theranostics、Cancer Immunotherapy and Biomarkers